Commonwealth legislation

Amendment of Statement of Principles concerning mesangial IGA glomerulonephritis No. 75 of 2002

RepealedCTH

This Act has been repealed and is no longer in force. It is retained for historical reference.

Jurisdiction

Commonwealth

Collection

legislative instrument

Plain English Summary

3/10 complexity

This update to veterans’ medical rules lets primary mesangial IgA glomerulonephritis be recognised as caused or aggravated by workplace solvent exposure, replacing an older broad solvent definition. Veterans who inhaled or had skin contact with specified oxygenated, aliphatic or aromatic organic solvents for an average of at least 2 hours per week over 12 months before disease onset or worsening may now qualify. It affects veterans claiming under the Veterans' Entitlements Act 1986.

JSON API

Deep dive

Want the full deep dive?

Zoe can write the in-depth analysis on top of the summary above: how it works, who it affects and what each part actually does.

Current sections

Direct links to the current provisions in Amendment of Statement of Principles concerning mesangial IGA glomerulonephritis No. 75 of 2002.

Amendment of Statement of Principles concerning mesangial IGA glomerulonephritis No. 75 of 2002

Instrument No.75 of 2002

Amendment of Statement of Principles

concerning

MESANGIAL IGA GLOMERULONEPHRITIS

Veterans’ Entitlements Act 1986

The Repatriation Medical Authority amends, under subsection 196B(2) of the Veterans’ Entitlements Act 1986 (the Act), Instrument No.63 of 2001 by:
in paragraph 5, deleting the factors (c) and (d) and inserting in their place the following factors:

“(c) for primary mesangial IgA glomerulonephritis only, inhaling or having dermal exposure to:

(i) oxygenated organic solvents,

(ii) aliphatic hydrocarbon solvents, or

(iii) aromatic hydrocarbon solvents,

for an average of at least two hours per week over a period of at least twelve months before the clinical onset of mesangial IgA glomerulonephritis; or

(d) for primary mesangial IgA glomerulonephritis only, inhaling or having dermal exposure to:

(i) oxygenated organic solvents,

(ii) aliphatic hydrocarbon solvents, or

(iii) aromatic hydrocarbon solvents,

for an average of at least two hours per week over a period of at least twelve months before the clinical worsening of mesangial IgA glomerulonephritis; or”

B. in paragraph 8, deleting the definition of “organic solvents”.

The amendments made by this instrument apply to all matters to which Instrument No.63 of 2001 and section 120A of the Act apply.

Dated this Twenty-First day of November 2002

The Common Seal of the )

Repatriation Medical Authority )

was affixed to this instrument )

in the presence of )

KEN DONALD

CHAIRMAN

Source text

Sourced from the Federal Register of Legislation (legislation.gov.au), CC BY 4.0.

1 Amendment of Statement of Principles concerning mesangial IGA glomerulonephritis No. 75 of 2002

Instrument No.75 of 2002

Amendment of Statement of Principles

concerning

MESANGIAL IGA GLOMERULONEPHRITIS

Veterans’ Entitlements Act 1986

The Repatriation Medical Authority amends, under subsection 196B(2) of the Veterans’ Entitlements Act 1986 (the Act), Instrument No.63 of 2001 by:
in paragraph 5, deleting the factors (c) and (d) and inserting in their place the following factors:

“(c) for primary mesangial IgA glomerulonephritis only, inhaling or having dermal exposure to:

(i) oxygenated organic solvents,

(ii) aliphatic hydrocarbon solvents, or

(iii) aromatic hydrocarbon solvents,

for an average of at least two hours per week over a period of at least twelve months before the clinical onset of mesangial IgA glomerulonephritis; or

(d) for primary mesangial IgA glomerulonephritis only, inhaling or having dermal exposure to:

(i) oxygenated organic solvents,

(ii) aliphatic hydrocarbon solvents, or

(iii) aromatic hydrocarbon solvents,

for an average of at least two hours per week over a period of at least twelve months before the clinical worsening of mesangial IgA glomerulonephritis; or”

B. in paragraph 8, deleting the definition of “organic solvents”.

The amendments made by this instrument apply to all matters to which Instrument No.63 of 2001 and section 120A of the Act apply.

Dated this Twenty-First day of November 2002

The Common Seal of the )

Repatriation Medical Authority )

was affixed to this instrument )

in the presence of )

KEN DONALD

CHAIRMAN